Stavudine Alternatives Compared
| Stavudine | Dovato (dolutegravir / lamivudine) | Bictegravir / emtricitabine / tenofovir alafenamide |
|
|---|
| Stavudine | Dovato (dolutegravir / lamivudine) | Bictegravir / emtricitabine / tenofovir alafenamide |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for HIV Infection, Nonoccupational Exposure. Stavudine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. Dovato may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. Bictegravir / emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
||||||||
| More about Stavudine | More about Dovato (dolutegravir / lamivudine) | More about Bictegravir / emtricitabine / tenofovir alafenamide | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Dovato has an average rating of 6.5 out of 10 from a total of 46 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 33% reported a negative effect. |
Bictegravir / emtricitabine / tenofovir alafenamide has an average rating of 7.2 out of 10 from a total of 218 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
|
Bictegravir / emtricitabine / tenofovir alafenamide side effects |
||||||||||
| Generic Availability | ||||||||||
|
Lower cost generic |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dovato prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
N/A |
Biktarvy | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
3.5 hours |
19 hours |
180 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 138 drugs are known to interact with Stavudine:
|
A total of 206 drugs are known to interact with Dovato:
|
A total of 436 drugs are known to interact with Bictegravir / emtricitabine / tenofovir alafenamide:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
June 24, 1994 |
April 08, 2019 |
February 07, 2018 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.